Authors:
Topol, EJ
Califf, RM
Van de Werf, F
Willerson, JT
Booth, J
White, H
Clayman, M
Deckelbaum, L
Lincoff, AM
Ohman, EM
Bates, E
Gibler, WB
Hochman, J
Kleiman, N
Grinfeld, L
Aylward, P
Armstrong, PW
Heikkila, J
Vahanian, A
Steg, G
Bode, C
Adgy, AAJ
Guetta, V
Ardissino, D
Savonitto, S
Bar, F
Simoons, M
Kontny, F
White, H
Sadowski, Z
Seabra-Gomes, R
Dalby, A
Betriu, A
Swahn, E
Wilcox, R
Frye, RL
Bertrand, ME
DeMets, D
Fox, KKA
Fuster, V
Lee, KL
McCarthy, C
Waller, M
Scherer, J
van de Kerkhove, A
Kukulewicz, L
Booth, JE
Del Valle, M
Hibert, D
Brannon, D
Citation: Ej. Topol et al., Reperfusion therapy for acute myocardial infarction with fibrinolytic therapy or combination reduced fibrinolytic therapy and platelet glycoprotein IIb/IIIa inhibition: the GUSTO randomised trial, LANCET, 357(9272), 2001, pp. 1905-1914
Authors:
Cho, L
Topol, EJ
Balog, C
Foody, JM
Booth, JE
Cabot, C
Kleiman, NS
Tcheng, JE
Califf, R
Lincoff, MA
Citation: L. Cho et al., Clinical benefit of glycoprotein IIb/IIIa blockade with abciximab is independent of gender - Pooled analysis from EPIC, EPILOG and EPISTENT trials, J AM COL C, 36(2), 2000, pp. 381-386
Authors:
Lincoff, AM
LeNarz, LA
Despotis, GJ
Smith, PK
Booth, JE
Raymond, RE
Sapp, SK
Cabot, CF
Tcheng, JE
Califf, RM
Effron, MB
Topol, EJ
Citation: Am. Lincoff et al., Abciximab and bleeding during coronary surgery: Results from the EPILOG and EPISTENT trials, ANN THORAC, 70(2), 2000, pp. 516-526
Authors:
Lincoff, AM
Califf, RM
Moliterno, DJ
Ellis, SG
Ducas, J
Kramer, JH
Kleiman, NS
Cohen, EA
Booth, JE
Sapp, SK
Cabot, CF
Topol, EJ
Citation: Am. Lincoff et al., Complementary clinical benefits of coronary-artery stenting and blockade of platelet glycoprotein IIb/IIIa receptors, N ENG J MED, 341(5), 1999, pp. 319-327
Authors:
Lincoff, AM
Tcheng, JE
Califf, RM
Kereiakes, DJ
Kelly, TA
Timmis, GC
Kleiman, NS
Booth, JE
Balog, C
Cabot, CF
Anderson, KM
Weisman, HF
Topol, EJ
Citation: Am. Lincoff et al., Sustained suppression of ischemic complications of coronary intervention by platelet GP IIb/IIIa blockade with abciximab - One-year outcome in the EPILOG trial, CIRCULATION, 99(15), 1999, pp. 1951-1958
Authors:
Marso, SP
Lincoff, AM
Ellis, SG
Bhatt, DL
Tanguay, JF
Kleiman, NS
Hammoud, T
Booth, JE
Sapp, SK
Topol, EJ
Citation: Sp. Marso et al., Optimizing the percutaneous interventional outcomes for patients with diabetes mellitus - Results of the EPISTENT (Evaluation of Platelet IIb/IIIa inhibitor for Stenting Trial) diabetic substudy, CIRCULATION, 100(25), 1999, pp. 2477-2484
Authors:
Scirica, BM
Moliterno, DJ
Every, NR
Anderson, FV
Aguirre, FV
Granger, CB
Lambrew, CT
Rabbani, LE
Arnold, A
Sapp, SK
Booth, JE
Ferguson, JJ
Cannon, CP
Citation: Bm. Scirica et al., Differences between men and women in the management of unstable angina pectoris (The GUARANTEE Registry), AM J CARD, 84(10), 1999, pp. 1145-1150
Authors:
Scirica, BM
Moliterno, DJ
Every, NR
Anderson, HV
Aguirre, FV
Granger, CB
Lambrew, CT
Rabbani, LE
Sapp, SK
Booth, JE
Ferguson, JJ
Cannon, CP
Citation: Bm. Scirica et al., Racial differences in the management of unstable angina: Results from the multicenter GUARANTEE registry, AM HEART J, 138(6), 1999, pp. 1065-1072